29.4 Percent of U.S. Pharmacies Operating in 2010-2021 Closed by 2021
By Elana Gotkine HealthDay Reporter
TUESDAY, Dec. 3, 2024 -- Almost 30 percent of U.S. pharmacies operating during 2010 to 2021 had closed by 2021, according to a study published in the December issue of Health Affairs.
Jenny S. Guadamuz, Ph.D., from the University of California in Berkley, and colleagues examined the number and percentage of pharmacy closures during 2010 to 2021 by linking data from the National Council for Prescription Drug Programs for all U.S. retail pharmacies to county-level data from the National Center for Health Statistics and ZIP Code Tabulation Area data from the American Community Survey.
The researchers found that 29.4 percent of the 88,930 retail pharmacies operating during 2010 to 2020 had closed by 2021. Compared with White neighborhoods, the risk for closure was higher for pharmacies in predominantly Black and Latinx neighborhoods. Across all neighborhood and market characteristics, independent pharmacies had a greater risk for closure than chain pharmacies.
"Federal, state, and local policies and programs should consider targeted strategies, including increases in Medicare Part D and Medicaid pharmacy reimbursement rates, to protect critical access pharmacies most at-risk for closure, particularly those serving neighborhoods that are or are at risk of becoming pharmacy deserts," senior author Dima Mazen Qato, Pharm.D., M.P.H., Ph.D., of the USC Mann School of Pharmacy and Pharmaceutical Sciences, said in a statement.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-05 00:00
Read more

- It Takes About A Year To Get Epilepsy Under Control For Most, Study Says
- Seniors With Certain Cardiovascular Diseases Saw Life's Essential 8 Scores Decline 2013 to 2018
- Stapokibart Found to Be Superior to Placebo for Severe Chronic Rhinosinusitis With Polyps
- Tdap, MenACWY Coverage Increased in Teens From 2023 to 2024
- Rusfertide Receives Breakthrough Therapy Designation for Treatment of Erythrocytosis in Patients with Polycythemia Vera
- Sensitive Personalities Tied to More Mental Health Conditions
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions